课题基金 / 基金详情

Enhancing Patient Survivorship: Leveraging Real-World Data to Develop Methods for Identifying Key Cancer Clinical Outcomes and Treatment Complications

Enhancing Patient Survivorship: Leveraging Real-World Data to Develop Methods for Identifying Key Cancer Clinical Outcomes and Treatment Complications
提高患者生存率:利用真实世界数据开发识别关键癌症临床结果和治疗并发症的方法
批准号:
489289
负责人:
Xu Yuan
金额:
$49.32万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
未结题
起止时间:
2023-09-01 至 2027-09-01

项目摘要

项目成果

Xu Yuan的其他基金

相关文献

中文摘要
翻译
在2022年,大约有233,900名加拿大人发现他们患有癌症。由于更好的检测和治疗,更多的人在癌症诊断后活得更长。但这也意味着我们需要关注癌症可能复发、新的癌症类型或si
英文摘要
In 2022, about 233,900 Canadians found out they had cancer. Thanks to better testing and treatments, more people are living longer after a cancer diagnosis. But this also means we need to pay attention to possible return of cancer, new cancer types, or si
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enhancing Patient Survivorship: Leveraging Real-World Data to Develop Methods for Identifying Key Cancer Clinical Outcomes and Treatment Complications
  • 批准号:
    498859
  • 项目类别:
    Operating Grants
  • 资助金额:
    $1.82万
  • 财政年份:
    2023
  • 负责人:
    Xu Yuan
  • 依托单位:
Generating EMR-Based Algorithms to Identify Hospital Adverse Events for Health System Performance Evaluation and Improvement
  • 批准号:
    435128
  • 项目类别:
    Operating Grants
  • 资助金额:
    $86.66万
  • 财政年份:
    2020
  • 负责人:
    Xu Yuan
  • 依托单位:
To develop analytical methodology for digital health information to leverage clinical decision-supporting and healthcare system performance assessment.
  • 批准号:
    387689
  • 项目类别:
    Fellowship Programs
  • 资助金额:
    $7.9万
  • 财政年份:
    2018
  • 负责人:
    Xu Yuan
  • 依托单位: